The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vaccine Administration Market Research Report 2024
Synopsis
The global Vaccine Administration market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Vaccine Administration, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Administration.
Report Scope
The Vaccine Administration market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine Administration market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine Administration companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
AstraZeneca
Sanofi Aventis
Merck
GlaxoSmithKline
Emergent BioSolutions
Johnson & Johnson
CSL Limited
Serum Institute of India
Bharat Biotech
VBI Vaccines
Sinovac Biotech
Segment by Type
Viral Diseases
Bacterial Diseases
Segment by Application
Paediatrics
Adults
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccine Administration companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Vaccine Administration market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Vaccine Administration, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Administration.
Report Scope
The Vaccine Administration market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine Administration market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine Administration companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
AstraZeneca
Sanofi Aventis
Merck
GlaxoSmithKline
Emergent BioSolutions
Johnson & Johnson
CSL Limited
Serum Institute of India
Bharat Biotech
VBI Vaccines
Sinovac Biotech
Segment by Type
Viral Diseases
Bacterial Diseases
Segment by Application
Paediatrics
Adults
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccine Administration companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccine Administration Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Viral Diseases
1.2.3 Bacterial Diseases
1.3 Market by Application
1.3.1 Global Vaccine Administration Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Paediatrics
1.3.3 Adults
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vaccine Administration Market Perspective (2019-2030)
2.2 Vaccine Administration Growth Trends by Region
2.2.1 Global Vaccine Administration Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Vaccine Administration Historic Market Size by Region (2019-2024)
2.2.3 Vaccine Administration Forecasted Market Size by Region (2025-2030)
2.3 Vaccine Administration Market Dynamics
2.3.1 Vaccine Administration Industry Trends
2.3.2 Vaccine Administration Market Drivers
2.3.3 Vaccine Administration Market Challenges
2.3.4 Vaccine Administration Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccine Administration Players by Revenue
3.1.1 Global Top Vaccine Administration Players by Revenue (2019-2024)
3.1.2 Global Vaccine Administration Revenue Market Share by Players (2019-2024)
3.2 Global Vaccine Administration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vaccine Administration Revenue
3.4 Global Vaccine Administration Market Concentration Ratio
3.4.1 Global Vaccine Administration Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccine Administration Revenue in 2023
3.5 Vaccine Administration Key Players Head office and Area Served
3.6 Key Players Vaccine Administration Product Solution and Service
3.7 Date of Enter into Vaccine Administration Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccine Administration Breakdown Data by Type
4.1 Global Vaccine Administration Historic Market Size by Type (2019-2024)
4.2 Global Vaccine Administration Forecasted Market Size by Type (2025-2030)
5 Vaccine Administration Breakdown Data by Application
5.1 Global Vaccine Administration Historic Market Size by Application (2019-2024)
5.2 Global Vaccine Administration Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Vaccine Administration Market Size (2019-2030)
6.2 North America Vaccine Administration Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Vaccine Administration Market Size by Country (2019-2024)
6.4 North America Vaccine Administration Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vaccine Administration Market Size (2019-2030)
7.2 Europe Vaccine Administration Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Vaccine Administration Market Size by Country (2019-2024)
7.4 Europe Vaccine Administration Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vaccine Administration Market Size (2019-2030)
8.2 Asia-Pacific Vaccine Administration Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Vaccine Administration Market Size by Region (2019-2024)
8.4 Asia-Pacific Vaccine Administration Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vaccine Administration Market Size (2019-2030)
9.2 Latin America Vaccine Administration Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Vaccine Administration Market Size by Country (2019-2024)
9.4 Latin America Vaccine Administration Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccine Administration Market Size (2019-2030)
10.2 Middle East & Africa Vaccine Administration Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Vaccine Administration Market Size by Country (2019-2024)
10.4 Middle East & Africa Vaccine Administration Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Vaccine Administration Introduction
11.1.4 Pfizer Revenue in Vaccine Administration Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Vaccine Administration Introduction
11.2.4 AstraZeneca Revenue in Vaccine Administration Business (2019-2024)
11.2.5 AstraZeneca Recent Development
11.3 Sanofi Aventis
11.3.1 Sanofi Aventis Company Detail
11.3.2 Sanofi Aventis Business Overview
11.3.3 Sanofi Aventis Vaccine Administration Introduction
11.3.4 Sanofi Aventis Revenue in Vaccine Administration Business (2019-2024)
11.3.5 Sanofi Aventis Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Vaccine Administration Introduction
11.4.4 Merck Revenue in Vaccine Administration Business (2019-2024)
11.4.5 Merck Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Vaccine Administration Introduction
11.5.4 GlaxoSmithKline Revenue in Vaccine Administration Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Emergent BioSolutions
11.6.1 Emergent BioSolutions Company Detail
11.6.2 Emergent BioSolutions Business Overview
11.6.3 Emergent BioSolutions Vaccine Administration Introduction
11.6.4 Emergent BioSolutions Revenue in Vaccine Administration Business (2019-2024)
11.6.5 Emergent BioSolutions Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Vaccine Administration Introduction
11.7.4 Johnson & Johnson Revenue in Vaccine Administration Business (2019-2024)
11.7.5 Johnson & Johnson Recent Development
11.8 CSL Limited
11.8.1 CSL Limited Company Detail
11.8.2 CSL Limited Business Overview
11.8.3 CSL Limited Vaccine Administration Introduction
11.8.4 CSL Limited Revenue in Vaccine Administration Business (2019-2024)
11.8.5 CSL Limited Recent Development
11.9 Serum Institute of India
11.9.1 Serum Institute of India Company Detail
11.9.2 Serum Institute of India Business Overview
11.9.3 Serum Institute of India Vaccine Administration Introduction
11.9.4 Serum Institute of India Revenue in Vaccine Administration Business (2019-2024)
11.9.5 Serum Institute of India Recent Development
11.10 Bharat Biotech
11.10.1 Bharat Biotech Company Detail
11.10.2 Bharat Biotech Business Overview
11.10.3 Bharat Biotech Vaccine Administration Introduction
11.10.4 Bharat Biotech Revenue in Vaccine Administration Business (2019-2024)
11.10.5 Bharat Biotech Recent Development
11.11 VBI Vaccines
11.11.1 VBI Vaccines Company Detail
11.11.2 VBI Vaccines Business Overview
11.11.3 VBI Vaccines Vaccine Administration Introduction
11.11.4 VBI Vaccines Revenue in Vaccine Administration Business (2019-2024)
11.11.5 VBI Vaccines Recent Development
11.12 Sinovac Biotech
11.12.1 Sinovac Biotech Company Detail
11.12.2 Sinovac Biotech Business Overview
11.12.3 Sinovac Biotech Vaccine Administration Introduction
11.12.4 Sinovac Biotech Revenue in Vaccine Administration Business (2019-2024)
11.12.5 Sinovac Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Vaccine Administration Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Viral Diseases
Table 3. Key Players of Bacterial Diseases
Table 4. Global Vaccine Administration Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Vaccine Administration Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Vaccine Administration Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Vaccine Administration Market Share by Region (2019-2024)
Table 8. Global Vaccine Administration Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Vaccine Administration Market Share by Region (2025-2030)
Table 10. Vaccine Administration Market Trends
Table 11. Vaccine Administration Market Drivers
Table 12. Vaccine Administration Market Challenges
Table 13. Vaccine Administration Market Restraints
Table 14. Global Vaccine Administration Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Vaccine Administration Market Share by Players (2019-2024)
Table 16. Global Top Vaccine Administration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Administration as of 2023)
Table 17. Ranking of Global Top Vaccine Administration Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Vaccine Administration Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Vaccine Administration Product Solution and Service
Table 21. Date of Enter into Vaccine Administration Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Vaccine Administration Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Vaccine Administration Revenue Market Share by Type (2019-2024)
Table 25. Global Vaccine Administration Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Vaccine Administration Revenue Market Share by Type (2025-2030)
Table 27. Global Vaccine Administration Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Vaccine Administration Revenue Market Share by Application (2019-2024)
Table 29. Global Vaccine Administration Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Vaccine Administration Revenue Market Share by Application (2025-2030)
Table 31. North America Vaccine Administration Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Vaccine Administration Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Vaccine Administration Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Vaccine Administration Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Vaccine Administration Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Vaccine Administration Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Vaccine Administration Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Vaccine Administration Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Vaccine Administration Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Vaccine Administration Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Vaccine Administration Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Vaccine Administration Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Vaccine Administration Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Vaccine Administration Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Vaccine Administration Market Size by Country (2025-2030) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Vaccine Administration Product
Table 49. Pfizer Revenue in Vaccine Administration Business (2019-2024) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. AstraZeneca Company Detail
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Vaccine Administration Product
Table 54. AstraZeneca Revenue in Vaccine Administration Business (2019-2024) & (US$ Million)
Table 55. AstraZeneca Recent Development
Table 56. Sanofi Aventis Company Detail
Table 57. Sanofi Aventis Business Overview
Table 58. Sanofi Aventis Vaccine Administration Product
Table 59. Sanofi Aventis Revenue in Vaccine Administration Business (2019-2024) & (US$ Million)
Table 60. Sanofi Aventis Recent Development
Table 61. Merck Company Detail
Table 62. Merck Business Overview
Table 63. Merck Vaccine Administration Product
Table 64. Merck Revenue in Vaccine Administration Business (2019-2024) & (US$ Million)
Table 65. Merck Recent Development
Table 66. GlaxoSmithKline Company Detail
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Vaccine Administration Product
Table 69. GlaxoSmithKline Revenue in Vaccine Administration Business (2019-2024) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Emergent BioSolutions Company Detail
Table 72. Emergent BioSolutions Business Overview
Table 73. Emergent BioSolutions Vaccine Administration Product
Table 74. Emergent BioSolutions Revenue in Vaccine Administration Business (2019-2024) & (US$ Million)
Table 75. Emergent BioSolutions Recent Development
Table 76. Johnson & Johnson Company Detail
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Vaccine Administration Product
Table 79. Johnson & Johnson Revenue in Vaccine Administration Business (2019-2024) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. CSL Limited Company Detail
Table 82. CSL Limited Business Overview
Table 83. CSL Limited Vaccine Administration Product
Table 84. CSL Limited Revenue in Vaccine Administration Business (2019-2024) & (US$ Million)
Table 85. CSL Limited Recent Development
Table 86. Serum Institute of India Company Detail
Table 87. Serum Institute of India Business Overview
Table 88. Serum Institute of India Vaccine Administration Product
Table 89. Serum Institute of India Revenue in Vaccine Administration Business (2019-2024) & (US$ Million)
Table 90. Serum Institute of India Recent Development
Table 91. Bharat Biotech Company Detail
Table 92. Bharat Biotech Business Overview
Table 93. Bharat Biotech Vaccine Administration Product
Table 94. Bharat Biotech Revenue in Vaccine Administration Business (2019-2024) & (US$ Million)
Table 95. Bharat Biotech Recent Development
Table 96. VBI Vaccines Company Detail
Table 97. VBI Vaccines Business Overview
Table 98. VBI Vaccines Vaccine Administration Product
Table 99. VBI Vaccines Revenue in Vaccine Administration Business (2019-2024) & (US$ Million)
Table 100. VBI Vaccines Recent Development
Table 101. Sinovac Biotech Company Detail
Table 102. Sinovac Biotech Business Overview
Table 103. Sinovac Biotech Vaccine Administration Product
Table 104. Sinovac Biotech Revenue in Vaccine Administration Business (2019-2024) & (US$ Million)
Table 105. Sinovac Biotech Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vaccine Administration Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Vaccine Administration Market Share by Type: 2023 VS 2030
Figure 3. Viral Diseases Features
Figure 4. Bacterial Diseases Features
Figure 5. Global Vaccine Administration Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Vaccine Administration Market Share by Application: 2023 VS 2030
Figure 7. Paediatrics Case Studies
Figure 8. Adults Case Studies
Figure 9. Vaccine Administration Report Years Considered
Figure 10. Global Vaccine Administration Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Vaccine Administration Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Vaccine Administration Market Share by Region: 2023 VS 2030
Figure 13. Global Vaccine Administration Market Share by Players in 2023
Figure 14. Global Top Vaccine Administration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Administration as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Vaccine Administration Revenue in 2023
Figure 16. North America Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Vaccine Administration Market Share by Country (2019-2030)
Figure 18. United States Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Vaccine Administration Market Share by Country (2019-2030)
Figure 22. Germany Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Vaccine Administration Market Share by Region (2019-2030)
Figure 30. China Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Vaccine Administration Market Share by Country (2019-2030)
Figure 38. Mexico Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Vaccine Administration Market Share by Country (2019-2030)
Figure 42. Turkey Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Vaccine Administration Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Pfizer Revenue Growth Rate in Vaccine Administration Business (2019-2024)
Figure 45. AstraZeneca Revenue Growth Rate in Vaccine Administration Business (2019-2024)
Figure 46. Sanofi Aventis Revenue Growth Rate in Vaccine Administration Business (2019-2024)
Figure 47. Merck Revenue Growth Rate in Vaccine Administration Business (2019-2024)
Figure 48. GlaxoSmithKline Revenue Growth Rate in Vaccine Administration Business (2019-2024)
Figure 49. Emergent BioSolutions Revenue Growth Rate in Vaccine Administration Business (2019-2024)
Figure 50. Johnson & Johnson Revenue Growth Rate in Vaccine Administration Business (2019-2024)
Figure 51. CSL Limited Revenue Growth Rate in Vaccine Administration Business (2019-2024)
Figure 52. Serum Institute of India Revenue Growth Rate in Vaccine Administration Business (2019-2024)
Figure 53. Bharat Biotech Revenue Growth Rate in Vaccine Administration Business (2019-2024)
Figure 54. VBI Vaccines Revenue Growth Rate in Vaccine Administration Business (2019-2024)
Figure 55. Sinovac Biotech Revenue Growth Rate in Vaccine Administration Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
